FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094198 [Registered on: 03/09/2025] Trial Registered Prospectively
Last Modified On: 01/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Better corneal endothelium cell protection during cataract surgery in Type 2 Diabetes Mellitus patients using different Ophthalmic viscosurgical devices 
Scientific Title of Study   Evaluation of outcome of two different Ophthalmic viscosurgical devices 3 percent Sodium Hyaluronate and 4 percent Chondroitin sulphate vs 2 percent Hydroxy propyl methyl cellulose on endothelial cell count in Phacoemulsifiction cataract surgery in Diabetics 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  NALIN SAH 
Designation  JUNIOR RESIDENT 
Affiliation  SANKARA EYE HOSPITAL GUNTUR 
Address  Sankara Eye Hospital,General Ophthalmology department, Guntur - Vijayawada Highway, Pedakakani, Andhra Pradesh

Guntur
ANDHRA PRADESH
522509
India 
Phone  07905033713  
Fax    
Email  greatnalin@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  ANEES FATIMA 
Designation  OPHTHALMOLOGY CONSULTANT 
Affiliation  SANKARA EYE HOSPITAL GUNTUR 
Address  Sankara Eye Hospital, General Ophthalmology Department, Guntur - Vijayawada Highway, Pedakakani, Andhra Pradesh

Guntur
ANDHRA PRADESH
522509
India 
Phone    
Fax    
Email  aneesfatima@sankaraeye.com  
 
Details of Contact Person
Public Query
 
Name  NALIN SAH 
Designation  JUNIOR RESIDENT 
Affiliation  SANKARA EYE HOSPITAL GUNTUR 
Address  Sankara Eye Hospital , General Ophthalmology Department Guntur - Vijayawada Highway, Pedakakani, Andhra Pradesh 522509

Guntur
ANDHRA PRADESH
522509
India 
Phone  07905033713  
Fax    
Email  greatnalin@gmail.com  
 
Source of Monetary or Material Support  
Sankara Eye Hospoital Guntur - Vijayawada Highway, Pedakakani, Andhra Pradesh , India 522509 
 
Primary Sponsor  
Name  Sankara eye hospital Guntur 
Address  Guntur - Vijayawada Highway, Pedakakani, Andhra Pradesh 522509 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nalin Sah  SANKARA EYE HOSPITAL   Guntur - Vijayawada Highway, General Ophthalmology Department , Pedakakani, Andhra Pradesh 522509
Guntur
ANDHRA PRADESH 
7905033713

greatnalin@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee SEH-Guntur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  3% Sodium Hyaluronate and 4% Chondroitin Sulphate,2% Hydroxy Propyl Methyl Cellulose  Evaluate the outcomes of two comparator devices on Endothelial cell count in Phacoemulsification cataract surgery of patients with Diabetes Mellitus above 50 years of age 
Intervention  3% Sodium Hyaluronate and 4% Chondroitin Sulphate,2% Hydroxy Propyl Methyl Cellulose  Evaluate the outcomes of two interventional devices on Endothelial cell count in Phacoemulsification cataract surgery of patients with Diabetes Mellitus above 50 years of age 
 
Inclusion Criteria  
Age From  50.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Grade of cataract- Nuclear sclerosis 1,2,3 and posterior subcapsular cataract 1,2,3,4 cortical cataract 1,2,3,4 by Lens Opacities Classification System(LOCS 3)
Pre operative Specular count>2000 cells/mm2
Uneventfull cataract surgery
Diagnosed with Type2 DM
 
 
ExclusionCriteria 
Details  Grade of cataract-Nuclear Sclerosis 4,5,6 posterior subcapsular cataract 5 cortical cataract 5 (Lens Opacities Classification System Grading 3)
Corneal pathologies like fuchs endothelial dystrophy
Ocular pathology like Uveitis, pseudoexfoliation, glaucoma
Trauma
Previous eye surgery
Small rigid pupil(less than 5 mm)
Subluxated cataract
Complicated cataract
Study subjects lost to follow-up
 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Alternation 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Endothelial Cell Count decrease to be evaluated in both groups of Ophthalmic Viscosurgical Devieces   Endothelial Cell Count decrease to be evaluated in both groups of Ophthalmic Viscosurgical Devieces at baseline, 1 week,1 month,3 months 
 
Secondary Outcome  
Outcome  TimePoints 
Central corneal thickness increase to be evaluated in both groups of Ophthalmic viscosurgical devices   Central corneal thickness increase to be evaluated in both groups of Ophthalmic viscosurgical devices at baseline , 1 week,1 month,1 month 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   23/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study is a prospective interventional randomized control trial evaluating the effects of 3 percent Sodium Hyaluronate and 4 percent Chondroitin Sulphate vs 2 percent Hydroxy Propyl Methyl Cellulose on Endothelial cell count in 80 diabetic patients above 50 years of age undergoing Phacoemulsification cataract surgery in one center in Guntur India. The primary outcomes measure will all show decrease in endothelial cell count in 1 week,1 month and 3 months. The secondary outcome will show increase in Central corneal thickness in 1 week,1 month and 3 months. 
Close